241 related articles for article (PubMed ID: 18201201)
1. Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase.
Zhang H; Deng JY; Bi LJ; Zhou YF; Zhang ZP; Zhang CG; Zhang Y; Zhang XE
FEBS J; 2008 Feb; 275(4):753-62. PubMed ID: 18201201
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.
Petrella S; Gelus-Ziental N; Maudry A; Laurans C; Boudjelloul R; Sougakoff W
PLoS One; 2011 Jan; 6(1):e15785. PubMed ID: 21283666
[TBL] [Abstract][Full Text] [Related]
3. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
Barco P; Cardoso RF; Hirata RD; Leite CQ; Pandolfi JR; Sato DN; Shikama ML; de Melo FF; Mamizuka EM; Campanerut PA; Hirata MH
J Antimicrob Chemother; 2006 Nov; 58(5):930-5. PubMed ID: 16971417
[TBL] [Abstract][Full Text] [Related]
4. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.
Singh P; Mishra AK; Malonia SK; Chauhan DS; Sharma VD; Venkatesan K; Katoch VM
J Commun Dis; 2006 Mar; 38(3):288-98. PubMed ID: 17373362
[TBL] [Abstract][Full Text] [Related]
5. Biochemical Characterization and Computational Identification of Mycobacterium tuberculosis Pyrazinamidase in Some Pyrazinamide-Resistant Isolates of Iran.
Doustdar F; Pazhang M; Mehrnejad F; Safarzadeh M; Rabiei D; Chaparzadeh N; Falahati H; Mir-Derikvand M
Protein J; 2015 Jun; 34(3):181-92. PubMed ID: 25972249
[TBL] [Abstract][Full Text] [Related]
6. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.
Zimic M; Sheen P; Quiliano M; Gutierrez A; Gilman RH
Infect Genet Evol; 2010 Mar; 10(2):346-9. PubMed ID: 19963078
[TBL] [Abstract][Full Text] [Related]
7. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
Scorpio A; Zhang Y
Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.
Seiner DR; Hegde SS; Blanchard JS
Biochemistry; 2010 Nov; 49(44):9613-9. PubMed ID: 20879713
[TBL] [Abstract][Full Text] [Related]
9. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Korea and analysis of the correlation between the mutations and pyrazinamidase activity.
Yoon JH; Nam JS; Kim KJ; Ro YT
World J Microbiol Biotechnol; 2014 Nov; 30(11):2821-8. PubMed ID: 25034468
[TBL] [Abstract][Full Text] [Related]
10. The carboxy-terminal end of the peptide deformylase from Mycobacterium tuberculosis is indispensable for its enzymatic activity.
Saxena R; Chakraborti PK
Biochem Biophys Res Commun; 2005 Jul; 332(2):418-25. PubMed ID: 15896710
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors.
Supo-Escalante RR; Médico A; Gushiken E; Olivos-Ramírez GE; Quispe Y; Torres F; Zamudio M; Antiparra R; Amzel LM; Gilman RH; Sheen P; Zimic M
PLoS One; 2020; 15(7):e0235643. PubMed ID: 32735615
[TBL] [Abstract][Full Text] [Related]
12. [Nicotinamidase and the so-called pyrazinamidase in mycobacteria; the simultaneous occurrence of both activites (author's transl)].
Tarnok I; Pechmann H; Krallmann-Wenzel U; Röhrscheidt E; Tarnok Z
Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):302-8. PubMed ID: 506551
[TBL] [Abstract][Full Text] [Related]
13. The curious characteristics of pyrazinamide: a review.
Zhang Y; Mitchison D
Int J Tuberc Lung Dis; 2003 Jan; 7(1):6-21. PubMed ID: 12701830
[TBL] [Abstract][Full Text] [Related]
14. Characterization and site-directed mutagenesis of the putative novel acyl carrier protein Rv0033 and Rv1344 from Mycobacterium tuberculosis.
Huang Y; Ge J; Yao Y; Wang Q; Shen H; Wang H
Biochem Biophys Res Commun; 2006 Apr; 342(2):618-24. PubMed ID: 16487939
[TBL] [Abstract][Full Text] [Related]
15. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
[TBL] [Abstract][Full Text] [Related]
16. Isolation and molecular characterization of a novel D-hydantoinase from Jannaschia sp. CCS1.
Cai Y; Trodler P; Jiang S; Zhang W; Wu Y; Lu Y; Yang S; Jiang W
FEBS J; 2009 Jul; 276(13):3575-88. PubMed ID: 19490017
[TBL] [Abstract][Full Text] [Related]
17. An EDTA-resistant pyrazinamidase from non-pathogen Pseudonocardia carboxydivorans.
Yan C; Zhang J; Wu P; Gan Y; Zhang G
Biotechnol Lett; 2020 Sep; 42(9):1707-1718. PubMed ID: 32323078
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic activity of Campylobacter jejuni hippurate hydrolase.
Steele M; Marcone M; Gyles C; Chan VL; Odumeru J
Protein Eng Des Sel; 2006 Jan; 19(1):17-25. PubMed ID: 16303789
[TBL] [Abstract][Full Text] [Related]
19. Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis.
Lemaitre N; Callebaut I; Frenois F; Jarlier V; Sougakoff W
Biochem J; 2001 Feb; 353(Pt 3):453-8. PubMed ID: 11171040
[TBL] [Abstract][Full Text] [Related]
20. Purification and molecular characterization of a novel diadenosine 5',5'''-P(1),P(4)-tetraphosphate phosphorylase from Mycobacterium tuberculosis H37Rv.
Mori S; Shibayama K; Wachino J; Arakawa Y
Protein Expr Purif; 2010 Jan; 69(1):99-105. PubMed ID: 19778616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
